advancing human health requires a greater understanding of biology, and that understanding starts with the cell. we enable researchers to drive exponential progress in oncology, immunology, neuroscience, and more with novel single cell, spatial, and in sit

10x Genomics, Inc. Class A Common Stock

Sold all TXG

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

Eric Weiner

New position in TXG

Camden Jones

Alexander Taussig

Sold 32% of TXG

Sold 44% of TXG

Bought 19% more TXG

Kyle

Bought 127% more TXG

Bought 214% more TXG

Mike Pelech

Bought 47% more TXG

Sold 50% of TXG

Jay Venkateswaran

Sold 12% of TXG

Sold 11% of TXG

Bought 100% more TXG

Bought to close all TXG

Taylor Duran